Cargando…

Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network

OBJECTIVE: Delineation of clinical target volume (CTV) and organs at risk (OARs) is important for radiotherapy but is time-consuming. We trained and evaluated a U-ResNet model to provide fast and consistent auto-segmentation. METHODS: We collected 160 patients’ CT scans with breast cancer who underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhikai, Liu, Fangjie, Chen, Wanqi, Tao, Yinjie, Liu, Xia, Zhang, Fuquan, Shen, Jing, Guan, Hui, Zhen, Hongnan, Wang, Shaobin, Chen, Qi, Chen, Yu, Hou, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572021/
https://www.ncbi.nlm.nih.gov/pubmed/34754241
http://dx.doi.org/10.2147/CMAR.S330249
_version_ 1784595140681138176
author Liu, Zhikai
Liu, Fangjie
Chen, Wanqi
Tao, Yinjie
Liu, Xia
Zhang, Fuquan
Shen, Jing
Guan, Hui
Zhen, Hongnan
Wang, Shaobin
Chen, Qi
Chen, Yu
Hou, Xiaorong
author_facet Liu, Zhikai
Liu, Fangjie
Chen, Wanqi
Tao, Yinjie
Liu, Xia
Zhang, Fuquan
Shen, Jing
Guan, Hui
Zhen, Hongnan
Wang, Shaobin
Chen, Qi
Chen, Yu
Hou, Xiaorong
author_sort Liu, Zhikai
collection PubMed
description OBJECTIVE: Delineation of clinical target volume (CTV) and organs at risk (OARs) is important for radiotherapy but is time-consuming. We trained and evaluated a U-ResNet model to provide fast and consistent auto-segmentation. METHODS: We collected 160 patients’ CT scans with breast cancer who underwent breast-conserving surgery (BCS) and were treated with radiotherapy. CTV and OARs were delineated manually and were used for model training. The dice similarity coefficient (DSC) and 95th percentile Hausdorff distance (95HD) were used to assess the performance of our model. CTV and OARs were randomly selected as ground truth (GT) masks, and artificial intelligence (AI) masks were generated by the proposed model. Two clinicians randomly compared CTV score differences of the contour. The consistency between two clinicians was tested. Time cost for auto-delineation was evaluated. RESULTS: The mean DSC values of the proposed method were 0.94, 0.95, 0.94, 0.96, 0.96 and 0.93 for breast CTV, contralateral breast, heart, right lung, left lung and spinal cord, respectively. The mean 95HD values were 4.31mm, 3.59mm, 4.86mm, 3.18mm, 2.79mm and 4.37mm for the above structures, respectively. The average CTV scores for AI and GT were 2.89 versus 2.92 when evaluated by oncologist A (P=0.612), and 2.75 versus 2.83 by oncologist B (P=0.213), with no statistically significant differences. The consistency between two clinicians was poor (kappa=0.282). The time for auto-segmentation of CTV and OARs was 10.03 s. CONCLUSION: Our proposed model (U-ResNet) can improve the efficiency and accuracy of delineation compared with U-Net, performing equally well with the segmentation generated by oncologists.
format Online
Article
Text
id pubmed-8572021
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85720212021-11-08 Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network Liu, Zhikai Liu, Fangjie Chen, Wanqi Tao, Yinjie Liu, Xia Zhang, Fuquan Shen, Jing Guan, Hui Zhen, Hongnan Wang, Shaobin Chen, Qi Chen, Yu Hou, Xiaorong Cancer Manag Res Original Research OBJECTIVE: Delineation of clinical target volume (CTV) and organs at risk (OARs) is important for radiotherapy but is time-consuming. We trained and evaluated a U-ResNet model to provide fast and consistent auto-segmentation. METHODS: We collected 160 patients’ CT scans with breast cancer who underwent breast-conserving surgery (BCS) and were treated with radiotherapy. CTV and OARs were delineated manually and were used for model training. The dice similarity coefficient (DSC) and 95th percentile Hausdorff distance (95HD) were used to assess the performance of our model. CTV and OARs were randomly selected as ground truth (GT) masks, and artificial intelligence (AI) masks were generated by the proposed model. Two clinicians randomly compared CTV score differences of the contour. The consistency between two clinicians was tested. Time cost for auto-delineation was evaluated. RESULTS: The mean DSC values of the proposed method were 0.94, 0.95, 0.94, 0.96, 0.96 and 0.93 for breast CTV, contralateral breast, heart, right lung, left lung and spinal cord, respectively. The mean 95HD values were 4.31mm, 3.59mm, 4.86mm, 3.18mm, 2.79mm and 4.37mm for the above structures, respectively. The average CTV scores for AI and GT were 2.89 versus 2.92 when evaluated by oncologist A (P=0.612), and 2.75 versus 2.83 by oncologist B (P=0.213), with no statistically significant differences. The consistency between two clinicians was poor (kappa=0.282). The time for auto-segmentation of CTV and OARs was 10.03 s. CONCLUSION: Our proposed model (U-ResNet) can improve the efficiency and accuracy of delineation compared with U-Net, performing equally well with the segmentation generated by oncologists. Dove 2021-11-02 /pmc/articles/PMC8572021/ /pubmed/34754241 http://dx.doi.org/10.2147/CMAR.S330249 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Zhikai
Liu, Fangjie
Chen, Wanqi
Tao, Yinjie
Liu, Xia
Zhang, Fuquan
Shen, Jing
Guan, Hui
Zhen, Hongnan
Wang, Shaobin
Chen, Qi
Chen, Yu
Hou, Xiaorong
Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title_full Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title_fullStr Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title_full_unstemmed Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title_short Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
title_sort automatic segmentation of clinical target volume and organs-at-risk for breast conservative radiotherapy using a convolutional neural network
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572021/
https://www.ncbi.nlm.nih.gov/pubmed/34754241
http://dx.doi.org/10.2147/CMAR.S330249
work_keys_str_mv AT liuzhikai automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT liufangjie automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT chenwanqi automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT taoyinjie automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT liuxia automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT zhangfuquan automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT shenjing automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT guanhui automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT zhenhongnan automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT wangshaobin automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT chenqi automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT chenyu automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork
AT houxiaorong automaticsegmentationofclinicaltargetvolumeandorgansatriskforbreastconservativeradiotherapyusingaconvolutionalneuralnetwork